Drawing on a rich scientific heritage and extensive international research, Emergex has developed collaborations in the US, EU, Singapore and Brazil with leading vaccine research bodies, including George Mason University in the US, the Institute of Molecular and Cell Biology (IMCB) of Singapore, and Brazil-based Bio-Manguinhos/Fiocruz.

Emergex will consider further collaboration and partnerships to accelerate its pipeline of vaccine candidates.

Please contact info@emergexvaccines.com to discuss opportunities with Emergex Vaccines and to arrange a meeting.